Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 1, 2021
Accession Number: 0000882104-21-000014
Submission Type: POS AM
CIK: 0000882104
Company Name: PDL BIOPHARMA, INC.
File Number: 333-87957